ResMed files new infringement action against Fisher & Paykel’s Simplus, Eson and Eson 2 masks in the International Trade Commission to stop their importation to and sale in the United States ResMed also files new district court action seeking monetary damages for and an injunction against sales of F&P’s Simplus, […]
Tag: RESMED
ResMed’s Astral Life Support Ventilator Now Has AutoEPAP in U.S.
ResMed today announced key upgrades to its Astral life support ventilators, including Optional AutoEPAP in iVAPS for U.S. patients, a high-demand therapy option. What is AutoEPAP? AutoEPAP (automatic expiratory positive airway pressure) automatically adjusts a patient’s expiratory pressure in response to flow limitations or obstruction of the upper airway. […]
SleepScore Labs Validation Study Shows Significant Sleep Benefits from Swannies Glasses
SleepScore Labs™, the company behind the most advanced non-contact sleep improvement system for consumers, has announced exciting results from its latest, scientific validation study. The study found that Swannies Blue Light Blocking Glasses from SleepScore ecosystem partner, Swanwick Sleep, contributed to measurably improved sleep quality when worn after sunset. SleepScore […]
SleepScore Mobile App Now Available to Android Users
Free app grants users worldwide access to their own scientifically validated SleepScore SleepScore, the definitive consumer standard of sleep measurement and improvement, today announced that its SleepScore mobile app – which turns mobile devices into a convenient, non-contact standalone sleep improvement system – is now available for free download on […]
Supplemental Oxygen Eliminates Morning Blood Pressure Rise in OSA Patients Following CPAP Withdrawal
Supplemental oxygen eliminates the rise in morning blood pressure experienced by obstructive sleep apnea (OSA) patients who stop using continuous positive airway pressure (CPAP), the standard treatment for OSA, according to new research published online in the American Thoracic Society’s American Journal of Respiratory and Critical Care Medicine. In “Effect […]
ResMed Enters Joint Venture to Find Untreated OSA Patients
ResMed and Verily, an Alphabet company, announced their agreement to form a new joint venture. Combining ResMed’s expertise in sleep apnea and Verily’s advanced health data analytics technologies, the U.S.-based joint venture will study the health and financial impacts of undiagnosed and untreated sleep apnea, and develop software solutions that […]
SleepScore Labs Launches World’s First Non-Contact Sleep Tracking App
SleepScore Labs, the company behind the definitive consumer standard of sleep measurement and improvement, announced the release of its free SleepScore mobile app, which can turn any smartphone into a non-contact, standalone sleep tracker. According to SleepScore Labs, at least 1.2 billion people worldwide suffer from a variety of sleep issues, […]
Switching to Bilevel PAP Saves 56% of Patients from Therapy Termination
“Bilevel Rescue” study presented at SLEEP 2018 conference A new study reveals that shifting patients who are struggling with adherence to positive airway pressure (PAP) therapy to a more advanced bilevel device in the first 90 days of treatment is an effective tool for achieving adherence in well more than […]
ResMed to Acquire HEALTHCAREfirst, a Cloud-based Software and Services Provider for Home Health and Hospice Agencies
The acquisition strengthens ResMed’s software-as-a-service (SaaS) solutions for homecare providers HEALTHCAREfirst offers electronic health record (EHR) software, billing and coding services, and advanced analytics that enable home health and hospice agencies to optimize their clinical, financial and administrative processes. HEALTHCAREfirst will complement ResMed’s existing software solutions offered by Brightree, a […]
Nearly 1 Billion People Worldwide Have Sleep Apnea
Researchers analyzed prevalence studies from 16 countries, together with data from the World Health Organization and United Nations World Population Prospects A new data analysis presented by ResMed this week at the ATS 2018 International Conference indicates that the prevalence of sleep apnea impacts more than 936 million people worldwide […]












